Evidence map›Paper›PMID 20848651›Full record

ArticleHuman mutation2010

Detection of clinically relevant exonic copy-number changes by array CGH.

Philip M Boone, Carlos A Bacino, Chad A Shaw, Patricia A Eng, Patricia M Hixson, Amber N Pursley, Sung-Hae L Kang, Yaping Yang, Joanna Wiszniewska, Beata A Nowakowska and 24 more

Abstract read
In one paragraph

Article in Human mutation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Homozygous Intragenic Deletion inMolecular syndromology · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Philip M BooneDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
Carlos A Bacino
Chad A Shaw
Patricia A Eng
Patricia M Hixson
Amber N Pursley
Sung-Hae L Kang
Yaping Yang
Joanna Wiszniewska
Beata A Nowakowska
Daniela del Gaudio
Zhilian Xia
Gayle Simpson-Patel
LaDonna L Immken
James B Gibson
Anne C-H Tsai
Jennifer A Bowers
Tyler E Reimschisel
Christian P Schaaf
Lorraine Potocki
Fernando Scaglia
Tomasz Gambin
Maciej Sykulski
Magdalena Bartnik
Katarzyna Derwinska
Barbara Wisniowiecka-Kowalnik
Seema R Lalani
Frank J Probst
Weimin Bi
Arthur L Beaudet
Ankita Patel
James R Lupski
Sau Wai Cheung
Pawel Stankiewicz

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007330 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 1985 to 2019
$15.6M
Human neurobehavioral phenotypes associates with the extended PWS/AS domainR01HD037283 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L. · 1999 to 2014
$8.4M
Nonrecurrent rearrangements, genome architecture and neurodegenerative disease.R01NS058529 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2009 to 2017
$5.0M
NICHD NIH HHS R01 HD037283NIGMS NIH HHS T32 GM007330NIGMS NIH HHS T32GM007330-34NINDS NIH HHS R01 NS058529NINDS NIH HHS R01NS058529
6 · The paper itself

Abstract

Array comparative genomic hybridization (aCGH) is a powerful tool for the molecular elucidation and diagnosis of disorders resulting from genomic copy-number variation (CNV). However, intragenic deletions or duplications--those including genomic intervals of a size smaller than a gene--have remained beyond the detection limit of most clinical aCGH analyses. Increasing array probe number improves genomic resolution, although higher cost may limit implementation, and enhanced detection of benign CNV can confound clinical interpretation. We designed an array with exonic coverage of selected disease and candidate genes and used it clinically to identify losses or gains throughout the genome involving at least one exon and as small as several hundred base pairs in size. In some patients, the detected copy-number change occurs within a gene known to be causative of the observed clinical phenotype, demonstrating the ability of this array to detect clinically relevant CNVs with subkilobase resolution. In summary, we demonstrate the utility of a custom-designed, exon-targeted oligonucleotide array to detect intragenic copy-number changes in patients with various clinical phenotypes.

Indexed as

AdolescentBase SequenceChildChild, PreschoolChromosome BreakpointsComparative Genomic HybridizationDNA Copy Number VariationsExonsFemaleGenetic Association StudiesHumansInfantInfant, NewbornMaleMolecular Sequence DataSequence Analysis, DNA

Identifiers

PMID20848651
PMCPMC3158569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.